H.I.G. Capital Acquires Taconic Biosciences

Avista Capital Partners Acquires Taconic Biosciences

November 1, 2022

Biotechnology

Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Taconic, a Rensselaer, New York–based provider of genetically engineered murine research models and related preclinical services, will leverage Avista's healthcare investing expertise to pursue organic growth and strategic acquisitions in the GEMs market.

Taconic Biosciences Acquires TransCure bioServices

January 20, 2026

Biotechnology

Taconic Biosciences has acquired TransCure bioServices SAS to create an integrated global translational research platform combining Taconic's genetically engineered and humanized mouse models with TransCure's preclinical in vivo services. The deal expands Taconic's capabilities across oncology, immunology, infectious disease, and advanced modalities while preserving TransCure's brand and operational structure to ensure continuity for employees and clients.

H.I.G. Capital Acquires BioVectra Inc.

November 4, 2019

Pharmaceuticals

H.I.G. Capital, through an affiliate, completed the acquisition of BioVectra Inc., a Canadian contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredients (APIs), intermediates and biologics. The deal — a carve-out from Mallinckrodt — positions H.I.G. to support BioVectra's growth and further expand its manufacturing capabilities across Charlottetown, Prince Edward Island and Windsor, Nova Scotia.

H.I.G. Capital Recapitalizes Navitas Life Sciences

September 13, 2022

Healthcare Services

An affiliate of H.I.G. Capital completed the recapitalization of Navitas Life Sciences, a Princeton, New Jersey–based technology-enabled clinical research organization (CRO). The transaction follows H.I.G.'s earlier agreement to acquire a majority (~75%) stake from TAKE Solutions and will provide Navitas with capital and resources to accelerate growth and expand its technology-enabled CRO capabilities.

H.I.G. Capital Acquires Barton & Associates

August 1, 2022

Healthcare Services

H.I.G. Capital, through one of its affiliates, has completed the acquisition of Barton & Associates, a Peabody, Massachusetts-based healthcare staffing company focused on locum tenens with capabilities in travel nursing, allied healthcare, and government physician staffing. The transaction positions Barton to scale its operations and meet rising demand for temporary clinical staffing across hospitals, health systems and government facilities.

H.I.G. Capital Acquires Celerion

November 3, 2022

Healthcare Services

H.I.G. Capital (through an affiliate) completed the acquisition of Celerion Holdings, Inc., a global clinical research organization headquartered in Lincoln, Nebraska. Celerion provides end-to-end early-stage clinical trial and bioanalytical services to pharmaceutical and biotechnology clients; H.I.G. said the investment expands its pharma services platform and supports Celerion's growth plans.